/PRNewswire/ ViewRay, Inc. (NASDAQ: VRAY) today announced that the University Hospitals (UH) Seidman Cancer Center in Cleveland has selected a MRIdian.
The Relief Stent in March secured its 510k clearance from the FDA, allowing it to be marketed in the U.S. for patients suffering from kidney stones and other issues causing difficulty draining the kidney.
Relief™ Stent, a new urinary stent invented by Lee Ponsky, MD, in collaboration with Dean Secrest, secured FDA 510k clearance, which means it can be marketed
The Relief Stent in March secured its 510k clearance from the U.S. Food and Drug Administration, allowing it to be marketed in the United States for patients suffering from kidney stones and other issues causing difficulty draining the kidney.